Global Nanomedicine Market to Reach $784.1 Billion by 2030

ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nanomedicine Industry" - https://www.reportlinker.com/p06343955/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Nanomedicine Market to Reach $784.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nanomedicine estimated at US$365.8 Billion in the year 2022, is projected to reach a revised size of US$784.1 Billion by 2030, growing at aCAGR of 10% over the period 2022-2030. Therapeutics, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$442.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Diagnostics segment is readjusted to a revised 12.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $99.7 Billion, While China is Forecast to Grow at 13.7% CAGR

The Nanomedicine market in the U.S. is estimated at US$99.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$171.4 Billion by the year 2030 trailing a CAGR of 13.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

Select Competitors (Total 231 Featured)
- Abbott Laboratories
- Celgene Corporation
- CombiMatrix Corporation
- GE Healthcare
- Johnson & Johnson
- Leadiant Biosciences, Inc.
- Mallinckrodt PLC
- Merck & Co., Inc.
- NanoSphere Health Sciences, Inc.
- Pfizer, Inc.


Read the full report: https://www.reportlinker.com/p06343955/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
Healthcare Nanotechnology (Nanomedicine) - Global Key
Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 4: World Nanomedicine Market Analysis of Annual Sales in
US$ Million for Years 2014 through 2030

Table 5: World Recent Past, Current & Future Analysis for
Nanomedicine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 6: World Historic Review for Nanomedicine by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 7: World 16-Year Perspective for Nanomedicine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030

Table 8: World Recent Past, Current & Future Analysis for
Therapeutics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 9: World Historic Review for Therapeutics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 10: World 16-Year Perspective for Therapeutics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 11: World Recent Past, Current & Future Analysis for
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 12: World Historic Review for Diagnostics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 13: World 16-Year Perspective for Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 14: World Recent Past, Current & Future Analysis for
Cardiovascular Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 15: World Historic Review for Cardiovascular Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 16: World 16-Year Perspective for Cardiovascular Diseases
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 17: World Recent Past, Current & Future Analysis for
Oncological Diseases by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 18: World Historic Review for Oncological Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 19: World 16-Year Perspective for Oncological Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 20: World Recent Past, Current & Future Analysis for
Infectious Diseases by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 21: World Historic Review for Infectious Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 22: World 16-Year Perspective for Infectious Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 23: World Recent Past, Current & Future Analysis for
Orthopedic Diseases by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 24: World Historic Review for Orthopedic Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 25: World 16-Year Perspective for Orthopedic Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 26: World Recent Past, Current & Future Analysis for
Neurological Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 27: World Historic Review for Neurological Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 28: World 16-Year Perspective for Neurological Diseases
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 29: World Recent Past, Current & Future Analysis for
Urological Diseases by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 30: World Historic Review for Urological Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 31: World 16-Year Perspective for Urological Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 32: World Recent Past, Current & Future Analysis for
Ophthalmological Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 33: World Historic Review for Ophthalmological Diseases
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 34: World 16-Year Perspective for Ophthalmological
Diseases by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 35: World Recent Past, Current & Future Analysis for
Immunological Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 36: World Historic Review for Immunological Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 37: World 16-Year Perspective for Immunological Diseases
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 38: World Recent Past, Current & Future Analysis for
Other Indications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 39: World Historic Review for Other Indications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 40: World 16-Year Perspective for Other Indications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 41: World Recent Past, Current & Future Analysis for
Regenerative Medicine by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 42: World Historic Review for Regenerative Medicine by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 43: World 16-Year Perspective for Regenerative Medicine
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 44: World Recent Past, Current & Future Analysis for Drug
Delivery by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 45: World Historic Review for Drug Delivery by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 46: World 16-Year Perspective for Drug Delivery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 47: World Recent Past, Current & Future Analysis for
Vaccines by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 48: World Historic Review for Vaccines by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 49: World 16-Year Perspective for Vaccines by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 50: World Recent Past, Current & Future Analysis for
Diagnostic Imaging by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 51: World Historic Review for Diagnostic Imaging by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 52: World 16-Year Perspective for Diagnostic Imaging by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 53: World Recent Past, Current & Future Analysis for
Implants by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 54: World Historic Review for Implants by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 55: World 16-Year Perspective for Implants by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Nanomedicine Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 56: USA Recent Past, Current & Future Analysis for
Nanomedicine by Application - Regenerative Medicine, Drug
Delivery, Vaccines, Diagnostic Imaging, Implants and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 57: USA Historic Review for Nanomedicine by Application -
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 58: USA 16-Year Perspective for Nanomedicine by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications for the Years 2014,
2023 & 2030

Table 59: USA Recent Past, Current & Future Analysis for
Nanomedicine by Modality - Therapeutics and Diagnostics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 60: USA Historic Review for Nanomedicine by Modality -
Therapeutics and Diagnostics Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 61: USA 16-Year Perspective for Nanomedicine by Modality -
Percentage Breakdown of Value Sales for Therapeutics and
Diagnostics for the Years 2014, 2023 & 2030

Table 62: USA Recent Past, Current & Future Analysis for
Nanomedicine by Indication - Cardiovascular Diseases,
Oncological Diseases, Infectious Diseases, Orthopedic Diseases,
Neurological Diseases, Urological Diseases, Ophthalmological
Diseases, Immunological Diseases and Other Indications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 63: USA Historic Review for Nanomedicine by Indication -
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 64: USA 16-Year Perspective for Nanomedicine by
Indication - Percentage Breakdown of Value Sales for
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications for the Years 2014, 2023 & 2030

CANADA
Table 65: Canada Recent Past, Current & Future Analysis for
Nanomedicine by Application - Regenerative Medicine, Drug
Delivery, Vaccines, Diagnostic Imaging, Implants and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 66: Canada Historic Review for Nanomedicine by
Application - Regenerative Medicine, Drug Delivery, Vaccines,
Diagnostic Imaging, Implants and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 67: Canada 16-Year Perspective for Nanomedicine by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications for the Years 2014,
2023 & 2030

Table 68: Canada Recent Past, Current & Future Analysis for
Nanomedicine by Modality - Therapeutics and Diagnostics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 69: Canada Historic Review for Nanomedicine by Modality -
Therapeutics and Diagnostics Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 70: Canada 16-Year Perspective for Nanomedicine by
Modality - Percentage Breakdown of Value Sales for Therapeutics
and Diagnostics for the Years 2014, 2023 & 2030

Table 71: Canada Recent Past, Current & Future Analysis for
Nanomedicine by Indication - Cardiovascular Diseases,
Oncological Diseases, Infectious Diseases, Orthopedic Diseases,
Neurological Diseases, Urological Diseases, Ophthalmological
Diseases, Immunological Diseases and Other Indications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 72: Canada Historic Review for Nanomedicine by Indication -
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 73: Canada 16-Year Perspective for Nanomedicine by
Indication - Percentage Breakdown of Value Sales for
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications for the Years 2014, 2023 & 2030

JAPAN
Nanomedicine Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 74: Japan Recent Past, Current & Future Analysis for
Nanomedicine by Application - Regenerative Medicine, Drug
Delivery, Vaccines, Diagnostic Imaging, Implants and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 75: Japan Historic Review for Nanomedicine by Application -
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 76: Japan 16-Year Perspective for Nanomedicine by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications for the Years 2014,
2023 & 2030

Table 77: Japan Recent Past, Current & Future Analysis for
Nanomedicine by Modality - Therapeutics and Diagnostics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 78: Japan Historic Review for Nanomedicine by Modality -
Therapeutics and Diagnostics Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 79: Japan 16-Year Perspective for Nanomedicine by
Modality - Percentage Breakdown of Value Sales for Therapeutics
and Diagnostics for the Years 2014, 2023 & 2030

Table 80: Japan Recent Past, Current & Future Analysis for
Nanomedicine by Indication - Cardiovascular Diseases,
Oncological Diseases, Infectious Diseases, Orthopedic Diseases,
Neurological Diseases, Urological Diseases, Ophthalmological
Diseases, Immunological Diseases and Other Indications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 81: Japan Historic Review for Nanomedicine by Indication -
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 82: Japan 16-Year Perspective for Nanomedicine by
Indication - Percentage Breakdown of Value Sales for
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications for the Years 2014, 2023 & 2030

CHINA
Nanomedicine Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 83: China Recent Past, Current & Future Analysis for
Nanomedicine by Application - Regenerative Medicine, Drug
Delivery, Vaccines, Diagnostic Imaging, Implants and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 84: China Historic Review for Nanomedicine by Application -
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 85: China 16-Year Perspective for Nanomedicine by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications for the Years 2014,
2023 & 2030

Table 86: China Recent Past, Current & Future Analysis for
Nanomedicine by Modality - Therapeutics and Diagnostics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 87: China Historic Review for Nanomedicine by Modality -
Therapeutics and Diagnostics Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 88: China 16-Year Perspective for Nanomedicine by
Modality - Percentage Breakdown of Value Sales for Therapeutics
and Diagnostics for the Years 2014, 2023 & 2030

Table 89: China Recent Past, Current & Future Analysis for
Nanomedicine by Indication - Cardiovascular Diseases,
Oncological Diseases, Infectious Diseases, Orthopedic Diseases,
Neurological Diseases, Urological Diseases, Ophthalmological
Diseases, Immunological Diseases and Other Indications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 90: China Historic Review for Nanomedicine by Indication -
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 91: China 16-Year Perspective for Nanomedicine by
Indication - Percentage Breakdown of Value Sales for
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications for the Years 2014, 2023 & 2030

EUROPE
Nanomedicine Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 92: Europe Recent Past, Current & Future Analysis for
Nanomedicine by Application - Regenerative Medicine, Drug
Delivery, Vaccines, Diagnostic Imaging, Implants and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 93: Europe Historic Review for Nanomedicine by
Application - Regenerative Medicine, Drug Delivery, Vaccines,
Diagnostic Imaging, Implants and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 94: Europe 16-Year Perspective for Nanomedicine by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications for the Years 2014,
2023 & 2030

Table 95: Europe Recent Past, Current & Future Analysis for
Nanomedicine by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 96: Europe Historic Review for Nanomedicine by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 97: Europe 16-Year Perspective for Nanomedicine by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2014, 2023 & 2030

Table 98: Europe Recent Past, Current & Future Analysis for
Nanomedicine by Modality - Therapeutics and Diagnostics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 99: Europe Historic Review for Nanomedicine by Modality -
Therapeutics and Diagnostics Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 100: Europe 16-Year Perspective for Nanomedicine by
Modality - Percentage Breakdown of Value Sales for Therapeutics
and Diagnostics for the Years 2014, 2023 & 2030

Table 101: Europe Recent Past, Current & Future Analysis for
Nanomedicine by Indication - Cardiovascular Diseases,
Oncological Diseases, Infectious Diseases, Orthopedic Diseases,
Neurological Diseases, Urological Diseases, Ophthalmological
Diseases, Immunological Diseases and Other Indications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 102: Europe Historic Review for Nanomedicine by
Indication - Cardiovascular Diseases, Oncological Diseases,
Infectious Diseases, Orthopedic Diseases, Neurological
Diseases, Urological Diseases, Ophthalmological Diseases,
Immunological Diseases and Other Indications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 103: Europe 16-Year Perspective for Nanomedicine by
Indication - Percentage Breakdown of Value Sales for
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications for the Years 2014, 2023 & 2030

FRANCE
Nanomedicine Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 104: France Recent Past, Current & Future Analysis for
Nanomedicine by Application - Regenerative Medicine, Drug
Delivery, Vaccines, Diagnostic Imaging, Implants and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 105: France Historic Review for Nanomedicine by
Application - Regenerative Medicine, Drug Delivery, Vaccines,
Diagnostic Imaging, Implants and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 106: France 16-Year Perspective for Nanomedicine by
Application - Percentage Breakdown of Value Sales for
Regenerative Medicine, Drug Delivery, Vaccines, Diagnostic
Imaging, Implants and Other Applications for the Years 2014,
2023 & 2030

Table 107: France Recent Past, Current & Future Analysis for
Nanomedicine by Modality - Therapeutics and Diagnostics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 108: France Historic Review for Nanomedicine by Modality -
Therapeutics and Diagnostics Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 109: France 16-Year Perspective for Nanomedicine by
Modality - Percentage Breakdown of Value Sales for Therapeutics
and Diagnostics for the Years 2014, 2023 & 2030

Table 110: France Recent Past, Current & Future Analysis for
Nanomedicine by Indication - Cardiovascular Diseases,
Oncological Diseases, Infectious Diseases, Orthopedic Diseases,
Neurological Diseases, Urological Diseases, Ophthalmological
Diseases, Immunological Diseases and Other Indications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 111: France Historic Review for Nanomedicine by
Indication - Cardiovascular Diseases, Oncological Diseases,
Infectious Diseases, Orthopedic Diseases, Neurological
Diseases, Urological Diseases, Ophthalmological Diseases,
Immunological Diseases and Other Indications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 112: France 16-Year Perspective for Nanomedicine by
Indication - Percentage Breakdown of Value Sales for
Cardiovascular Diseases, Oncological Diseases, Infectious
Diseases, Orthopedic Diseases, Neurological Diseases,
Urological Diseases, Ophthalmological Diseases, Immunological
Diseases and Other Indications for the Years 2014, 2023 & 2030

GERMANY
Nanomedicine Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2023 (E)
Table 113: Germany Recent Past, Current & Future Analysis for
Nanomedicine by Application - Regenerative Medicine, Drug
Delivery, Vaccines, Diagnostic Imaging, Implants and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 114: Germany Historic Review for Nanomedicine by
Application - Regenerative Medicine, Drug Delivery, Vaccines,
Diagnostic Imaging, Implants and Other Applications Markets -

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06343955/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001